Differential Contributions of C3, C5, and Decay-Accelerating Factor to Ethanol-Induced Fatty Liver in Mice

Gastroenterology

Volumn 132, Issue 3, 2007, Pages 1117-1126

  Pritchard, Michele T ^a   McMullen, Megan R ^a   Stavitsky, Abram B ^b   Cohen, Jessica I ^a   Lin, Feng ^a   Medof, M Edward ^a   Nagy, Laura E ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5; DECAY ACCELERATING FACTOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; CENTRAL DEPRESSANT AGENT; CYTOCHROME P450 2E1; GAMMA INTERFERON; INTERLEUKIN 6;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DISEASE COURSE; FATTY LIVER; FEMALE; HEPATITIS; LIPID STORAGE; LIVER CELL DAMAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE; ALCOHOLIC FATTY LIVER; ANIMAL; BIOSYNTHESIS; BLOOD; C57BL MOUSE; DISEASE MODEL; ENZYME INDUCTION; ENZYMOLOGY; GENETICS; LIVER; METABOLISM; MOUSE MUTANT; PATHOLOGY;

ALANINE TRANSAMINASE; ANIMALS; ANTIGENS, CD55; CENTRAL NERVOUS SYSTEM DEPRESSANTS; COMPLEMENT C3; COMPLEMENT C3A; COMPLEMENT C5; CYTOCHROME P-450 CYP2E1; DISEASE MODELS, ANIMAL; ENZYME INDUCTION; ETHANOL; FATTY LIVER, ALCOHOLIC; FEMALE; INTERFERON TYPE II; INTERLEUKIN-6; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33947320624     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.01.053     Document Type: Article

References (51)

1. Monsinjon T., Gasque P., Chan P., Ischenko A., Brady J.J., and Fontaine M.C. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells. FASEB J 17 (2003) 1003-1014
2. Schieferdecker H.L., Schlaf G., Jungermann K., and Gotze O. Functions of anaphylatoxin C5a in rat liver: direct and indirect actions on nonparenchymal and parenchymal cells. Int Immunopharmacol 1 (2001) 469-481
3. DiScipio R.G., Daffern P.J., Jagels M.A., Broide D.H., and Sriramarao P. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo. J Immunol 162 (1999) 1127-1136
4. Jauneau A.C., Ischenko A., Chan P., and Fontaine M. Complement component anaphylatoxins upregulate chemokine expression by human astrocytes. FEBS Lett 537 (2003) 17-22
5. Thurman R.G. Mechanisms of Hepatic Toxicity II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol 275 (1998) G605-G611
6. Tilg H., and Diehl A.M. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 343 (2000) 1467-1476
7. Hoek J.B., and Pastorino J.G. Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol 27 (2002) 63-68
8. Jaeschke H., Gores G.J., Cederbaum A.I., Hinson J.A., Pessayre D., and Lemasters J.J. Mechanisms of hepatotoxicity. Toxicol Sci 65 (2002) 166-176
9. Adachi Y., Bradford B.U., Gao W., Bojes H.K., and Thurman R.G. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology 20 (1994) 453-460
10. Bode C., Kugler V., and Bode J.C. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol 4 (1987) 8-14
11. Fukui H., Brauner B., Bode J., and Bode C. Plasma endotoxin concentrations in patients with alcoholic and nonalcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol 12 (1991) 162-169
12. Nanji A.A., Khettry U., Sadrzadeh S.M.H., and Yamanaka T. Severity of liver injury in experimental alcoholic liver disease: Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4 and thromboxane B2. Am J Pathol 142 (1993) 367-373
13. Jarvelainen H.A., Vakeva A., Lindros K.O., and Meri S. Activation of complement components and reduced regulator expression in alcohol-induced liver injury in the rat. Clin Immunol 105 (2002) 57-63
14. Bykov I., Junnikkala S., Pekna M., Lindros K.O., and Meri S. Complement C3 contributes to ethanol-induced liver steatosis in mice. Ann Med 38 (2006) 280-286
15. Lin F., Fukuoka Y., Spicer A., Ohta R., Okada N., Harris C.L., Emancipator S.N., and Medof M.E. Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies. Immunology 104 (2001) 215-225
16. Wessels M.R., Butko P., Ma M., Warren H.B., Lage A.L., and Carroll M.C. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci U S A 92 (1995) 11490-11494
17. Markiewski M.M., Mastellos D., Tudoran R., DeAngelis R.A., Strey C.W., Franchini S., Wetsel R.A., Erdei A., and Lambris J.D. C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury. J Immunol 173 (2004) 747-754
18. Mastellos D., Prechl J., Laszlo G., Papp K., Olah E., Argyropoulos E., Franchini S., Tudoran R., Markiewski M., Lambris J.D., and Erdei A. Novel monoclonal antibodies against mouse C3 interfering with complement activation: description of fine specificity and applications to various immunoassays. Mol Immunol 40 (2004) 1213-1221
19. Walport M.J. Complement. First of two parts. N Engl J Med 344 (2001) 1058-1066
20. Minagawa M., Deng Q., Liu Z.X., Tsukamoto H., and Dennert G. Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-alpha during alcohol consumption. Gastroenterology 126 (2004) 1387-1399
21. Nagy L.E. New insights into the role of the innate immune response in the development of alcoholic liver disease. Exp Biol Med 228 (2003) 882-890
22. Strey C.W., Markiewski M., Mastellos D., Tudoran R., Spruce L.A., Greenbaum L.E., and Lambris J.D. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J Exp Med 198 (2003) 913-923
23. Tuma D.J., and Casey C.A. Dangerous byproducts of alcohol breakdown-focus on adducts. Alcohol Res Health 27 (2003) 285-290
24. Martinez-Hernandez A., and Amenta P.S. The hepatic extracellular matrix II. Ontogenesis, regeneration and cirrhosis. Virchows Arch A Pathol Anat Histopathol 423 (1993) 77-84
25. Koteish A., and Diehl A.M. Animal models of steatosis. Semin Liver Dis 21 (2001) 89-104
26. Hines I.N., and Wheeler M.D. Recent advances in alcoholic liver disease III. Role of the innate immune response in alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol 287 (2004) G310-G314
27. Cianflone K., Xia Z., and Chen L.Y. Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim Biophys Acta 1609 (2003) 127-143
28. Kildsgaard J., Zsigmond E., Chan L., and Wetsel R.A. A critical evaluation of the putative role of C3adesArg (ASP) in lipid metabolism and hyperapobetalipoproteinemia. Mol Immunol 36 (1999) 869-876
29. Pajvani U.B., Hawkins M., Combs T.P., Rajala M.W., Doebber T., Berger J.P., Wagner J.A., Wu M., Knopps A., Xiang A.H., Utzschneider K.M., Kahn S.E., Olefsky J.M., Buchanan T.A., and Scherer P.E. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 279 (2004) 12152-12162
30. Crabb D.W., Galli A., Fischer M., and You M. Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha. Alcohol 34 (2004) 35-38
31. Fischer M., You M., Matsumoto M., and Crabb D.W. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice. J Biol Chem 278 (2003) 27997-28004
32. You M., Considine R.V., Leone T.C., Kelly D.P., and Crabb D.W. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology 42 (2005) 568-577
33. Janeway C.A., Travers P., Walport M., and Shlomchik M. Innate immunity in immunobiology (2001), Garland, New York 57-58
34. Albrecht E.A., Chinnaiyan A.M., Varambally S., Kumar-Sinha C., Barrette T.R., Sarma J.V., and Ward P.A. C5a-induced gene expression in human umbilical vein endothelial cells. Am J Pathol 164 (2004) 849-859
35. Clark J.D., Qiao Y., Li X., Shi X., Angst M.S., and Yeomans D.C. Blockade of the complement C5a receptor reduces incisional allodynia, edema, and cytokine expression. Anesthesiology 104 (2006) 1274-1282
36. Daniel D.S., Dai G., Singh C.R., Lindsey D.R., Smith A.K., Dhandayuthapani S., Hunter Jr. R.L., and Jagannath C. The reduced bactericidal function of complement C5-deficient murine macrophages is associated with defects in the synthesis and delivery of reactive oxygen radicals to mycobacterial phagosomes. J Immunol 177 (2006) 4688-4698
37. Harkin D.W., Marron C.D., Rother R.P., Romaschin A., Rubin B.B., and Lindsay T.F. C5 complement inhibition attenuates shock and acute lung injury in an experimental model of ruptured abdominal aortic aneurysm. Br J Surg 92 (2005) 1227-1234
38. de Vries B., Kohl J., Leclercq W.K., Wolfs T.G., van Bijnen A.A., Heeringa P., and Buurman W.A. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J Immunol 170 (2003) 3883-3889
39. Fischer W.H., and Hugli T.E. Regulation of B cell functions by C3a and C3a(desArg): suppression of TNF-alpha, IL-6, and the polyclonal immune response. J Immunol 159 (1997) 4279-4286
40. Takabayashi T., Vannier E., Burke J.F., Tompkins R.G., Gelfand J.A., and Clark B.D. Both C3a and C3a(desArg) regulate interleukin-6 synthesis in human peripheral blood mononuclear cells. J Infect Dis 177 (1998) 1622-1628
41. Takabayashi T., Vannier E., Clark B.D., Margolis N.H., Dinarello C.A., Burke J.F., and Gelfand J.A. A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis. J Immunol 156 (1996) 3455-3460
42. Kildsgaard J., Hollmann T.J., Matthews K.W., Bian K., Murad F., and Wetsel R.A. Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock. J Immunol 165 (2000) 5406-5409
43. Addis-Lieser E., Kohl J., and Chiaramonte M.G. Opposing regulatory roles of complement factor 5 in the development of bleomycin-induced pulmonary fibrosis. J Immunol 175 (2005) 1894-1902
44. Hawlisch H., Belkaid Y., Baelder R., Hildeman D., Gerard C., and Kohl J. C5a negatively regulates toll-like receptor 4-induced immune responses. Immunity 22 (2005) 415-426
45. Wetsel R.A., and Kolb W.P. Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments. J Exp Med 157 (1983) 2029-2048
46. Huber-Lang M., Sarma J.V., Zetoune F.S., Rittirsch D., Neff T.A., McGuire S.R., Lambris J.D., Warner R.L., Flierl M.A., Hoesel L.M., Gebhard F., Younger J.G., Drouin S.M., Wetsel R.A., and Ward P.A. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 12 (2006) 682-687
47. Thurman R.G. Mechanisms of hepatic toxicity II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol 275 (1998) G605-G611
48. Kono H., Bradford B.U., Yin M., Sulik K.K., Koop D.R., Peters J.M., Gonzalez F.J., McDonald T., Dikalova A., Kadiiska M.B., Mason R.P., and Thurman R.G. CYP2E1 is not involved in early alcohol-induced liver injury. Am J Physiol Gastrointest Liver Physiol 277 (1999) G1259-G1267
49. McKim S.E., Gabele E., Isayama F., Lambert J.C., Tucker L.M., Wheeler M.D., Connor H.D., Mason R.P., Doll M.A., Hein D.W., and Arteel G.E. Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice. Gastroenterology 125 (2003) 1834-1844
50. McMullen M.R., Pritchard M.T., Wang Q., Millward C.A., Croniger C.M., and Nagy L.E. Early growth response-1 transcription factor is essential for ethanol-induced fatty liver injury in mice. Gastroenterology 128 (2005) 2066-2076
51. Uesugi T., Froh M., Arteel G.E., Bradford B.U., Wheeler M.D., Gabele E., Isayama F., and Thurman R.G. Role of lipopolysaccharide-binding protein in early alcohol-induced liver injury in mice. J Immunol 168 (2002) 2963-2969